Canada’s $50M Vaccine Injury Program Faces Delays, Complaints

The Canadian Vaccine Injury Support Program (VISP), established with a $50 million budget to compensate individuals seriously injured by COVID-19 vaccines, is facing significant criticism for poor administration and delays, with many claimants reporting long waits and insufficient support. Investigations reveal that a substantial portion of the funds has gone to administration rather than direct compensation, and numerous claims remain unresolved years after submission. Personal stories from claimants highlight the severe and lasting health impacts experienced after vaccination, with some cases still languishing in the intake process. The Public Health Agency of Canada’s choice of the consulting firm Oxaro Inc. to administer VISP has been questioned amid reports of inadequate preparedness and unprofessional workplace behavior. Despite these challenges, the vaccination campaign was credited with reducing COVID-19 spread and easing hospital burdens. Meanwhile, in the United States, the Vaccine Integrity Project is mobilizing experts to develop evidence-based immunization guidelines for influenza, RSV, and COVID-19, aiming to uphold vaccine science amid shifts in federal vaccine policy and public health advisory structures.